Evrofarma SA (ATH:EVROF)
3.860
-0.010 (-0.26%)
Oct 1, 2026, 5:11 PM EET
| Market Cap | 52.77M +48.4% |
| Revenue (ttm) | 51.59M +6.6% |
| Net Income | 4.32M +60.7% |
| EPS | 0.32 +60.8% |
| Shares Out | 13.67M |
| PE Ratio | 12.20 |
| Forward PE | n/a |
| Dividend | 0.06 (1.55%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 467 |
| Open | 3.890 |
| Previous Close | 3.870 |
| Day's Range | 3.800 - 3.890 |
| 52-Week Range | 2.380 - 4.370 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 25, 2026 |